Silk, S., Kalinga, W., Salkeld, J., Mtaka, I., Ahmed, S., Milando, F., . . . Minassian, A. (2024). Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial. Elsevier.
Citación estilo ChicagoSilk, SE, et al. Blood-stage Malaria Vaccine Candidate RH5.1/Matrix-M in Healthy Tanzanian Adults and Children; an Open-label, Non-randomised, First-in-human, Single-centre, Phase 1b Trial. Elsevier, 2024.
Cita MLASilk, SE, et al. Blood-stage Malaria Vaccine Candidate RH5.1/Matrix-M in Healthy Tanzanian Adults and Children; an Open-label, Non-randomised, First-in-human, Single-centre, Phase 1b Trial. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.